(Matthews, North Carolina) – CEM Corporation is proud to announce the release of its Liberty 2.0 instrumentation line, the next generation of automated microwave peptide synthesizers. The Liberty 2.0 series continues to advance CEM’s award-winning SPPS technology, with developments resulting in enhanced peptide purity, remarkable synthesis efficiency, and exceptional automation reliability. The Liberty 2.0 series, […]

Seasoned Healthcare Executive Brings Extensive Life Sciences Experience to Company VERNON HILLS, Ill. — Antylia Scientific, a global leader of Molecular Diagnostic Reagents and Specialty Chemicals, Water and Air Quality Testing Equipment and Consumables, and Laboratory Products for the pharma, healthcare and environmental markets, announced today that Syed Jafry has joined its Board of Directors. Antylia is a […]

Hannover Medical School study will evaluate the use of whole-genome sequencing to show positive impact of earlier diagnosis and treatment for children with suspected genetic disorders SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced an agreement with Germany’s Hannover Medical School (Medizinische Hochschule Hannover (MHH)) to […]

Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Paul Beastall as Chair of the Board of Directors. Paul was previously a Non-Executive Director at Evonetix, having joined the Board in 2020. His new appointment to Chair will see him take a more involved […]

Developed with novel dye technology and AI guidance, new BD Horizon RealYellow™ 586 Reagents have potential to accelerate discovery and drug development in oncology, autoimmune disorders and infectious diseases FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new family of reagents […]

Biomedical relationships knowledge will boost applications in drug discovery for data scientists Manually curated information on biomedical relationships, complete with causality and context Researchers gain flexible access to high-quality data for mining and integration with their processes Redwood City, California, and Hilden, Germany – QIAGEN Digital Insights, the bioinformatics business of QIAGEN, today announced the launch […]

New Customer Represents Leading-Edge Scientific Research AMSTERDAM — LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced that it has completed a new installation of its revolutionary z-Movi® Cell Avidity Analyzer in the lab of Prof. Dirk Busch, Professor of Medical Microbiology, Immunology and Hygiene at the School of Medicine, Technical […]

MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced an expanded research collaboration with Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, to use the multi-omics capabilities of PacBio’s Sequel IIe system in the study of genetic disease. The research will apply direct methylation […]

SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has joined the Storage Networking Industry Association (SNIA www.snia.org) as a voting member. SNIA is a nonprofit organization made up of storage professionals and is the globally recognized and […]

Significant enhancements to the Sequel II/IIe platform include methylation calling in native DNA, greatly accelerated sample preparation, and support for gene therapy applications MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the release of a transformative capability to detect DNA methylation using the Sequel IIe and Sequel […]